Page 50 - AN-3-4

Advanced Neurology Anticoagulants as neuroprotective therapeutics

in patients with atrial fibrillation: A systematic review and 152. Kalloo AE, Slouha E, Gallagher CP, Razeq Z, Gorantla VR.
meta-analysis. Clin Cardiol. 2023;46(8):866-876. Anticoagulants and dementia: A systematic review. Cureus.
2023;15(5):e39693.
doi: 10.1002/clc.24076
doi: 10.7759/cureus.39693
143. Grymonprez M, Petrovic M, De Backer TL, Ikram MA,
Steurbaut S, Lahousse L. Comparing the risk of dementia 153. Ruff CT, Giugliano RP, Braunwald E, et al. Comparison
in subjects with atrial fibrillation using non-vitamin of the efficacy and safety of new oral anticoagulants with
K antagonist oral anticoagulants versus vitamin K warfarin in patients with atrial fibrillation: A meta-analysis
antagonists: A Belgian nationwide cohort study. Age Ageing. of randomised trials. Lancet. 2014;383(9921):955-962.
2023;52(3):afad038.
doi: 10.1016/S0140-6736(13)62343-0
doi: 10.1093/ageing/afad038
154. Lip GYH, Keshishian A, Li X, et al. Effectiveness and safety
144. Cadogan SL, Powell E, Wing K, Wong AY, Smeeth L, Warren- of oral anticoagulants among nonvalvular atrial fibrillation
Gash C. Anticoagulant prescribing for atrial fibrillation and patients. Stroke. 2018;49(12):2933-2944.
risk of incident dementia. Heart. 2021;107(23):1898-1904.
doi: 10.1161/STROKEAHA.118.020232
doi: 10.1136/heartjnl-2021-319672
155. Fanning L, Lau WCY, Mongkhon, P, et al. Safety and
145. Branco DR, Alves M, Sousa CS, Costa J, Ferreira JJ, effectiveness of direct oral anticoagulants vs warfarin in
Caldeira D. Direct oral anticoagulants vs vitamin K antagonist people with atrial fibrillation and dementia. J Am Med Dir
on dementia risk in atrial fibrillation: Systematic review with Assoc. 2020;21(8):1058-1064.
meta-analysis. J Thromb Thrombolysis. 2023;56(3):474-484.
doi: 10.1016/j.jamda.2019.11.022
doi: 10.1007/s11239-023-02843-5
156. Bonand C, Garcia-Blas S, Llergo JT, et al. Direct oral
146. Fong KY, Chan YH, Wang Y, et al. Dementia risk of direct anticoagulants versus warfarin in octogenarians with
oral anticoagulants versus warfarin for atrial fibrillation: nonvalvular atrial fibrillation: A systematic review and
Systematic review and meta-analysis. JACC: Asia. meta-analysis. J Clin Med. 2021;10(22):5268.
2023;3(5):776-786.
doi: 10.3390/jcm10225268
doi: 10.1016/j.jacasi.2023.07.012
157. Graham DJ, Reichman ME, Wernecke M, et al. Cardiovascular,
147. Caramelli B, Yu PC, Cardozo FAM, et al. Effects of dabigatran bleeding, and mortality risks in elderly medicare patients
versus warfarin on 2-year cognitive outcomes in old patients treated with dabigatran or warfarin for nonvalvular atrial
with atrial fibrillation: Results from the GIRAF randomized fibrillation. Circulation. 2015;131(2):157-164.
clinical trial. BMC Medicine. 2022;20(1):374.
doi: 10.1161/CIRCULATIONAHA.114.012061
doi: 10.1186/s12916-022-02563-2
158. Graham DJ, Reichman ME, Wernecke M, et al. Stroke,
148. Søgaard M, Skjøth F, Jensen M, et al. Nonvitamin K bleeding, and mortality risks in elderly medicare beneficiaries
antagonist oral anticoagulants versus warfarin in atrial treated with dabigatran or rivaroxaban for nonvalvular atrial
fibrillation patients and risk of dementia: A nationwide fibrillation. JAMA Intern Med. 2016;176(11):1662-1671.
propensity-weighted cohort study. J Am Heart Assoc. doi: 10.1001/jamainternmed.2016.5954
2019;8(11):e011358.
159. Ferro CJ, Solkhon F, Jalal Z, Al-Hamid AM, Jones AM.
doi: 10.1161/JAHA.118.011358
Relevance of physicochemical properties and functional
149. Thunell J, Wood K, Wharton W, Joyce G, Ferido P, pharmacology data to predict the clinical safety profile
Zissimopoulos J. Population dementia incidence and direct of direct oral anticoagulants. Pharmacol Res Perspect.
oral anticoagulant use in a representative population with 2020;8(3):e00603.
atrial fibrillation. Neurology. 2024;103(1):e209568.
doi: 10.1002/prp2.603
doi: 10.1212/WNL.0000000000209568
160. Lopez-Lopez JA, Sterne JA, Thom HHZ, et al. Oral
150. Kalantarian S, Stern T, Mansour M, Ruskin JN. Cognitive anticoagulants for prevention of stroke in atrial fibrillation:
impairment associated with atrial fibrillation: A meta- Systematic review, network meta-analysis, and cost
analysis. Ann Intern Med. 2013;158(5 pt 1):338-346. effectiveness analysis. BMJ. 2017;359:j5058.
doi: 10.7326/0003-4819-158-5-201303050-00007 doi: 10.1136/bmj.j5058
151. Silva RMF, Miranda CM, Liu T, Tse G, Roever L. Atrial 161. Connolly MD, Ezekowitz MD, Yusus S, et al. Dabigatran
fibrillation and risk of dementia: Epidemiology, mechanisms, versus warfarin in patients with atrial fibrillation. N Engl J
and effect of anticoagulation. Front Neurosci. 2019;13:18. Med. 2009;361(12):1139-1151.
doi: 10.3389/fnins.2019.00018 doi: 10.1056/NEJMoa0905561

Volume 3 Issue 4 (2024) 32 doi: 10.36922/an.3799